TOR1B and breast cancer: The results demonstrated that TOR1B upregulation was significantly associated with earlier BM in ER + (E-MTAB-365, p = 0.0159 and GSE2034, p = 0.00182) and PR + (E-MTAB-365, p = 0.00742) BC, and patients who were younger than 55 years were more vulnerable (E-MTAB-365, p = 0.0182) to early metastasis (Fig. 5).